LifeMD, Inc. LFMD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 188.94M | 192.04M | 193.78M | 194.50M | 192.77M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 188.94M | 192.04M | 193.78M | 194.50M | 192.77M |
| Cost of Revenue | 25.48M | 24.30M | 25.85M | 28.06M | 30.43M |
| Gross Profit | 163.45M | 167.74M | 167.93M | 166.44M | 162.34M |
| SG&A Expenses | 166.23M | 169.88M | 165.42M | 156.93M | 157.06M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 11.56M | 10.89M | 10.72M | 9.92M | 9.58M |
| Total Operating Expenses | 210.56M | 212.32M | 209.28M | 202.26M | 204.27M |
| Operating Income | -21.62M | -20.28M | -15.50M | -7.75M | -11.50M |
| Income Before Tax | -21.50M | -21.57M | -17.50M | -10.27M | -14.65M |
| Income Tax Expenses | 13.90K | 45.70K | 45.70K | 45.70K | 629.80K |
| Earnings from Continuing Operations | -21.51 | -21.62 | -17.54 | -10.32 | -15.28 |
| Earnings from Discontinued Operations | 21.03M | 21.97M | 23.86M | 25.85M | 6.25M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 20.70K | -228.80K | -733.90K | -1.27M | -1.60M |
| Net Income | -462.50K | 117.80K | 5.58M | 14.27M | -10.63M |
| EBIT | -21.62M | -20.28M | -15.50M | -7.75M | -11.50M |
| EBITDA | -20.33M | -19.04M | -14.38M | -6.79M | -4.58M |
| EPS Basic | -0.07 | -0.06 | 0.05 | 0.23 | -0.31 |
| Normalized Basic EPS | -0.28 | -0.27 | -0.24 | -0.16 | -0.14 |
| EPS Diluted | -0.07 | -0.06 | 0.05 | 0.23 | -0.32 |
| Normalized Diluted EPS | -0.28 | -0.27 | -0.24 | -0.16 | -0.14 |
| Average Basic Shares Outstanding | 190.08M | 188.06M | 184.67M | 180.47M | 175.91M |
| Average Diluted Shares Outstanding | 190.08M | 188.06M | 184.67M | 180.47M | 175.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -671.65% | 2,637.01% | 55.65% | 21.77% | -29.22% |